Change in Epigenome-Wide DNA Methylation Over 9 Years and Subsequent Mortality: Results From the InCHIANTI Study

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 71, Issue 8, 2016, Pages 1029-1035

  Moore, Ann Zenobia ^a,d   Hernandez, Dena G ^a   Tanaka, Toshiko ^a   Pilling, Luke C ^b   Nalls, Mike A ^a   Bandinelli, Stefania ^c   Singleton, Andrew B ^a   Ferrucci, Luigi ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^c SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^d Biomedical Research Center   (United States)

Author keywords

Chronological age; Epigenome wide DNA methylation; Survival

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; AGING; BLOOD; BLOOD CELL COUNT; BODY MASS; CROSS-SECTIONAL STUDY; DNA METHYLATION; EPIGENETICS; FEMALE; FOLLOW UP; GENETICS; HUMAN; LONGEVITY; MALE; MIDDLE AGED; MORTALITY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AGING; BIOMARKERS; BLOOD CELL COUNT; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DNA METHYLATION; EPIGENOMICS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGEVITY; MALE; MIDDLE AGED; MORTALITY;

EID: 84981218712     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glv118     Document Type: Article

References (25)

1. Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153(6):1194-1217. doi:10.1016/j.cell.2013.05.039
2. Brooks-Wilson AR. Genetics of healthy aging and longevity. Hum Genet. 2013;132(12):1323-1338. doi:10.1007/s00439-013-1342-z
3. Bjornsson HT, Fallin MD, Feinberg AP. An integrated epigenetic and genetic approach to common human disease. Trends Genet. 2004;20(8):350-358. doi:10.1016/j.tig.2004.06.009
4. Talens RP, Christensen K, Putter H, et al. Epigenetic variation during the adult lifespan: cross-sectional and longitudinal data on monozy-gotic twin pairs. Aging Cell. 2012;11(4):694-703. doi:10.1111/j.1474-9726.2012.00835.x
5. Bjornsson HT, Sigurdsson MI, Fallin MD, et al. Intra-individual change over time in DNA methylation with familial clustering. JAMA. 2008;299(24):2877-2883. doi:10.1001/jama.299.24.2877
6. Fraga MF, Ballestar E, Paz MF, et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A. 2005;102(30):10604-10609. doi:10.1073/pnas.0500398102
7. Lu Q. The critical importance of epigenetics in autoimmunity. J Autoimmun. 2013;41:1-5. doi:10.1016/j.jaut.2013.01.010
8. Baccarelli A, Ghosh S. Environmental exposures, epigenetics and cardiovascular disease. Curr Opin Clin Nutr Metab Care. 2012;15(4):323-329. doi:10.1097/MCO.0b013e328354bf5c
9. Feinberg AP. Phenotypic plasticity and the epigenetics of human disease. Nature. 2007;447(7143):433-440. doi:10.1038/nature05919
10. Heyn H, Li N, Ferreira HJ, et al. Distinct DNA methylomes of newborns and centenarians. Proc Natl Acad Sci U S A. 2012;109(26):10522-10527. doi:10.1073/pnas.1120658109
11. Hannum G, Guinney J, Zhao L, et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell. 2013;49(2):359-367. doi:10.1016/j.molcel.2012.10.016
12. Hernandez DG, Nalls MA, Gibbs JR, et al. Distinct DNA methylation changes highly correlated with chronological age in the human brain. Hum Mol Genet. 2011;20(6):1164-1172. doi:10.1093/hmg/ddq561
13. Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14(10):R115. doi:10.1186/gb-2013-14-10-r115
14. Ferrucci L, Bandinelli S, Benvenuti E, et al. Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the In CHIANTI study. J Am Geriatr Soc. 2000;48(12):1618-1625. doi:10.1111/j.1532-5415.2000.tb03873.x
15. Gibbs JR, van der Brug MP, Hernandez DG, et al. Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet. 2010;6(5):e1000952. doi:10.1371/journal. pgen.1000952
16. Holly AC, Pilling LC, Hernandez D, et al. Splicing factor 3B1 hypomethylation is associated with altered SF3B1 transcript expression in older humans. Mech Ageing Dev. 2014;135:50-56. doi:10.1016/j.mad.2014.01.005
17. Pidsley RY, Wong CC, Volta M, Lunnon K, Mill J, Schalkwyk LC. A datadriven approach to preprocessing Illumina 450K methylation array data. BMC Genomics. 2013;14:293. doi:10.1186/1471-2164-14-293
18. Chen YA, Lemire M, Choufani S, et al. Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium Human Methylation 450 microarray. Epigenetics. 2013;8(2):203-209. doi:10.4161/epi.23470
19. Tamura T, Yanai H, Savitsky D, Taniguchi T. The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol. 2008;26:535-584. doi:10.1146/annurev.immunol.26.021607.090400
20. Brustle A, Heink S, Huber M, et al. The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat Immunol. 2007;8(9):958-966. doi:10.1038/ni1500
21. Zheng Y, Chaudhry A, Kas A, et al. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature. 2009;458(7236):351-356. doi:10.1038/nature07674
22. Neumann M, Naumann M. Beyond Ikappa Bs: alternative regulation of NF-kappa B activity. FASEB J. 2007;21(11):2642-2654. doi:10.1096/fj.06-7615rev
23. Diaz-Meco MT, Moscat J. The atypical PKCs in inflammation: NF-κB and beyond. Immunol Rev. 2012;246(1):154-167. doi:10.1111/j.1600-065X.2012.01093.x
24. Moscat J, Rennert P, Diaz-Meco MT. PKCzeta at the crossroad of NF-kappa B and Jak1/Stat6 signaling pathways. Cell Death Differ. 2006;13(5):702-711. doi:10.1038/sj.cdd.4401823
25. Singh T, Newman AB. Inflammatory markers in population studies of aging. Ageing Res Rev. 2011;10(3):319-329. doi:10.1016/j. arr.2010.11.002